Thank you for subscribing!

Cannabis Global Leads With Quality and Innovation

Disrupting a $17 Billion Market

2020 was a breakout year for the American cannabis market, amassing $17.6 billion in sales nationally, marking a 46% increase over 2019. Now, 25 years after the march toward legalization in the United States began, that same market is expected to reach $42 billion by 2026. 

Cannabis Global, Inc. (OTC: CBGL) is a vertically-integrated company leading the industry in the creation of high-quality cannabis products and new technologies. Based in Los Angeles, California, Cannabis Global is enjoying strong Q/Q revenue growth in an industry primed for massive sustained growth in the coming years.

Drawing Intrigue from Investors

Centered in a Growth Industry
While the U.S. is making strides toward federal legalization, individual states continue to see their cannabis markets grow each year. Illinois expanded its legalization to adult-use at the start of 2020, for example, and its $784 million revenue rise represented the largest dollar gain of the year. Meanwhile, Cannabis Global’s home state of California increased its own sales by $586 million, making the Golden State a $3.5 billion cannabis market just five years after it made recreational use legal.

These are just two examples of how the market continues to grow in individual states and why the overall legal, recreational market is projected to reach $73 billion by 2027.

Enjoying the Ride
How does Cannabis Global succeed in creating high-quality products? They are ahead of the curve on research in their industry and have targeted two underserved, up-and-coming sectors of the market: nanotechnologies and cannabis infusion. Their intellectual property and techniques to address each have the potential to disrupt the entire industry.

Leading in Research and Innovation

Browsing through published media on Cannabis Global or flipping through the several patent applications the company has filed reveals two phrases: cannabis infusion and nanoparticle technologies

These terms represent a heavy focus for Cannabis Global and serve as a window for investors to see into potential future success, with the bulk of their research and development aimed at each.

What Is Cannabis Infusion?

Many everyday products are infused with cannabis, their extracts, or even the flavors and aromas of cannabis. This goes for everything from beauty products to oils for cooking, snack foods, drinks, and more. 

Cannabis Global believes one of the most underserved marketplaces relates to the delivery of these extracts to the human body. For many cannabis-based brands, infusion is done by spraying an extract over the product. Cannabis Global exceeds that status quo with their infused products. 

Prior to the passing of the Farm Bill of 2018, which made hemp legal at the federal level, research into cannabis and hemp infusion was severely limited. In response, the company began investing heavily into the research and development of new technologies that will advance administering cannabinoids to the human body. By January of 2020, they had already filed five patents on hemp extract technologies and delivery systems alone.

What Are Nanoparticle Technologies?

Cannabinoids are hydrophobic, making them inefficient for the human body to absorb. This presents a massive challenge in the pharmaceutical and nutraceutical (eg: nutritional supplements) industries where cannabis is used for health purposes. 

Nanotechnology is being hailed as the next big thing in the cannabis industry, breaking down molecules and possibly increasing their bioavailability in the human body. This allows for cannabis products to be more accurately dosed and effective when used for pharmaceutical purposes, as well as making cannabis a more viable alternative to mainstream medicine. 

In July CBGL released the details of its most recent non-provisional patent application for electrosprayed and electrospun cannabinoid compositions. Their invention will allow makers of cannabis products to create them with “selectable release parameters,” which has applications to both slow-release cannabinoids and fast-acting cannabinoid deliveries in beverages, foods, topical treatments, and other applications.

Cannabis Global Products:

“In crowded, highly competitive Southern California, we need to have unique products, and that is exactly what we have created,”  CEO of Cannabis Global, Arman Tabatabaei said earlier this year. “We are confident that cannabis consumers and our investors will be impressed with our new products. We have undoubtedly taken a product track toward ultra-premium products, as we believe this underserved area shows increasing consumer interest.” 

As majority owner of licensed cannabis manufacturer Natural Plant Extract (NPE) and licensed distribution company Northern Light Distribution, Cannabis Global has introduced multiple branded products in their field, from top-shelf cannabis flower products to stevia-enhanced cannabis candies and more. 

There are several products in production as well as available to the public through Cannabis Global, Natural Plant Extract, and Northern Lights Distribution. Below is another product recently released by Cannabis Global:

Comply Bag

Consumer products get plenty of attention, but products that an entire industry can rely on and put to use can be game changers. As the United States makes strides toward federal legalization, the shipping of cannabis-based products must be safe, secure, traceable, and in compliance with the regulations of individual states. 

Comply Bag is a clear container designed for the delivery of cannabis products, equipped with tamper-evident seams and sequential numbering containing both the tracking information and product information. This ensures that what’s manufactured and shipped is exactly what is delivered and eventually purchased by a consumer. 

“Cannabis is a big business, and as business continues to expand, it is even more vital to track and secure all shipments,” CEO of Cannabis Global, Arman Tabatabaei says. Tracking and securing shipments will be increasingly critical as the potential for national legalization materializes, and interstate commerce becomes more probable.

 

Market Outlook and Federal Legalization

Most U.S. states have legalized marijuana to varying degrees, some for medical use only while others permit recreational use. Most recently, 15 states had a cannabis legalization measure on their 2020 election ballots and all 15 voted in favor, creating a sweep for the industry. It’s also an indication of growing favor toward cannabis for medical use and recreational use within the public’s consciousness. 

As an industry, each new state to join the legalization trend creates a brand new market for distributors of cannabis products. The number of cannabis consumers is expected to continue to grow, with close to 50 million consumers by 2025. And even with the threat of economic depression due to the COVID-19 pandemic, cannabis sales experienced a massive financial boom throughout 2020, suggesting it may be a recession-proof industry. 

“It’s unclear which cannabis sector trends will actually be codified in major policy changes,” Cannabis Global wrote in early 2021. “While it’s true the democrats have control over Congress, their hold over the Senate is very slim,” acknowledging that cannabis policy change will continue through “piecemeal legislation.”

Why Cannabis Global?

Cannabis Global is thriving in a growing industry, with the potential to become a leader as the global market drives towards its projected $91.5 billion in revenue by 2028. Their branded products give consumers quality that is always in demand. But their continued efforts to contribute innovative and exciting intellectual property to the industry is something that can truly give investors optimism.


Press Releases:

Management:

Arman Tabatabaei, CEO & Chairman

Arman Tabatabaei is the founder of Cannabis Global and holds nearly two decades of experience in management and operations. He’s helped revamp operations at Sugarmade, Inc’s hydroponic growth supplies initiatives, as well as consulted with Cannabis Strategic Ventures on growth initiatives in cannabis cultivation and hemp-related retail operations.


Edward Manolos,
Director

One of Cannabis Global’s founders, Edward Manolos is hailed as a pioneer in California’s medical marijuana industry. He opened Los Angeles’ first medical marijuana dispensary in 2004 and has managed and operated more than 35 between LA and San Jose since. Along with holding other positions in the field, Mr. Manolos also founded Natural Plant Extracts of California, securing distribution and delivery licenses and distribution contracts with some of the state’s largest Cannabis brands.

 

 

DISCLAIMER

Who are we and what do we do? We are paid advertisers, also known as stock touts or stock promoters, who disseminate favorable information (the “Information”) about publicly traded companies (the “Profiled Issuers”). How is the Information published? We publish the Information on our Website, in newsletters, audio services, live interviews, featured “research” reports, on message boards and in email communications for specific time periods that are agreed upon between us and the Profiled Issuer or third party paying us. Our publication of the Information is known as a “Campaign”. Will everyone receive the Information at the same time? No. The Information may be sent to potential investors at different times that are minutes, hours, days or even weeks apart. How is a potential investor impacted if he receives the Information later than other investors? Typically, the trading volume and price of a Profiled Issuer’s securities increases after the Information is provided to the first group of investors. Therefore, the later an investor receives the Information, the more likely it is that he will suffer increased trading losses if he purchases the securities of a Profiled Issuer. What will happen to the shares that we hold during the Campaign? We will sell the shares we hold while we tell investors to purchase during the Campaign. What will happen when the Campaign ends? Most, if not all, of the Profiled Issuers are penny stocks that are illiquid and whose securities are subject to wide fluctuations in trading price and volume. During the Campaign the trading volume and price of the securities of each Profiled Issuer will likely increase significantly. When the Campaign ends, the volume and price of the Profiled Issuer will likely decrease dramatically. As a result, investors who purchase during the Campaign and hold shares of the Profiled Issuer when the Campaign ends will probably lose most, if not all, of their investment. Why do we publish only favorable Information? We only publish favorable information because we are compensated to publish only favorable information. Why don’t we publish negative Information? We don’t publish negative information because we are not paid to publish negative information. We are paid to publish only favorable information. Is the Information complete, accurate, truthful or reliable? No. The Information is a snapshot that provides only positive information about the Profiled Issuers. The Information consists of only positive content. We do not and will not publish any negative information about the Profiled Issuers; accordingly, investors should consider the Information to be one-sided and not balanced, complete, accurate, truthful or reliable. What we do not do? We do not publish negative information about the Profiled Issuers. We do not verify or confirm any portion of the Information. We do not conduct any due diligence, nor do we research any aspect of the Information including the completeness, accuracy, truthfulness or reliability of the Information. We do not review the Profiled Issuers’ financial condition, operations, business model, management or risks involved in the Profiled Issuer’s business or an investment in a Profiled Issuer’s securities. Where does the Information come from? The Information is provided to us by the Profiled Issuers and/or the person who hires us. We may also obtain the Information from publicly available sources such as the OTC Markets, Google, NASDAQ, NYSE, the Securities and Exchange Commission’s Edgar database or other available public sources. If we say we make “stock picks,” are those picks our own? No, they are not. We are compensated to advertise the securities we are told to advertise. What will happen if an investor relies on the Information? If an investor relies on the Information in making an investment decision it is highly probable that the investor will lose most, if not all, of his or her investment. Investors should not rely on the Information to make an investment decision. Who pays us to publish the Information? The source of our compensation varies depending upon the particular circumstances of the Campaign. We are compensated by the Profiled Issuers, third party shareholders and other parties related to the Profiled Issuers such as officers and/or directors who will derive a financial or other benefit from an increase in the trading price and/or volume of a Profiled Issuer’s securities. The nature and amount of compensation we receive for publishing the Information about each Profiled Issuer and our ownership of each Profiled Issuer is set forth below under the heading captioned, “What we are compensated”. What warranties do we make about the Information? None. We make no warranty or representation about the Information, including its completeness, accuracy, truthfulness or reliability and we disclaim, expressly and implicitly, all warranties of any kind, including whether the Information is complete, accurate, truthful, or reliable and as such, your use of the Information is at your own risk. The Information is provided as is without limitation. What we are not. We are not and do not act in the capacity of any of the following; as such, you should not construe our activities as involving any of the following:
  • An independent adviser or consultant;
  • A fortune teller;
  • An investment adviser or an entity engaging in activities that would be deemed to be providing investment advice that requires registration either at the federal or state level;
  • A broker-dealer or an individual acting in the capacity of a registered representative or broker;
  • A stock picker;
  • A securities trading expert;
  • A securities researcher or analyst;
  • A financial planner or one who engages in financial planning;
  • A provider of stock recommendations;
  • A provider of advice about buy, sell or hold recommendations as to specific securities; or
  • An agent offering or securities for sale or soliciting their purchase.
Are risks in this disclaimer the only risks investors should be aware of? No. There are numerous risks associated with each Profiled Issuer and investors should undertake a full review of each Profiled Issuer with the assistance of their financial, legal, and tax advisers prior to purchasing the securities of any Profiled Issuer. What conflicts of interest do we have in publishing the Information? We are not objective or independent and have multiple conflicts of interest. The Profiled Issuers and parties hiring us have conflicts of interest. What will happen to the shares that we hold during the Campaign? We will sell the shares we hold while we tell investors to purchase. Our publication of the Information involves actual and material conflicts of interest including but not limited to the following:
  • We receive monetary and/or securities compensation in exchange for publishing the (favorable) Information about the Profiled Issuers;
  • We do not publish any negative information whatsoever about the Profiled Issuers;
  • We may own a Profiled Issuer’s securities that we acquired from the Profiled Issuer, third parties or from our own open market purchases before, during or after the Campaign and we may sell these securities during the Campaign while publishing the (favorable) information that instructs investors to purchase. Our selling of a Profiled Issuer’s securities will likely cause investors to suffer losses;
  • A short time after we acquire a Profiled Issuer’s securities, we may publish the (favorable) Information about the Profiled Issuer advising others, including you, to purchase; and while doing so, we may sell the Profiled Issuer’s securities we acquired during our public dissemination of the Information causing us to profit while you suffer a loss;
  • Parties holding a Profiled Issuer’s securities, including those who engage our services and/or compensate us, will sell their shares of the Profiled Issuer while we are publishing the (favorable) Information.
Who is responsible if an investor relies on the Information? The investor. We are not responsible or liable for any person’s use of the Information or any success or failure that is directly or indirectly related to such person’s use of the Information because we have specifically stated that the information is not reliable and should not be relied upon for any purpose. We are not responsible for omissions or errors in the Information, and we are not responsible for actions taken by any person who relies upon the Information. What do we urge potential investors to do? We urge Investors to conduct their own in-depth investigation of the Profiled Issuers with the assistance of their legal, tax and investment advisers. An investor’s review of the Information should include but not be limited to the Profiled Issuer’s financial condition, operations, management, products or services, trends in the industry and risks that may be material to the profiled Issuer’s business and other information he and his advisers deem material to an investment decision. An investor’s review should include, but not be limited to a review of available public sources and information received directly from the Profiled Issuers or from websites such as Google, OTC Markets, NASDAQ, NYSE, www.sec.gov or other available public sources. Why is this Disclaimer being provided? We are providing you with this disclaimer because we are publishing advertisements about penny stocks. Because we are paid to disseminate the Information to the public about securities, we are required by the securities laws including Section 10(b) of the Securities Exchange Act of 1934 (the “Exchange Act”) and Rule 10b-5 thereunder, and Section 17(b) of the Securities Act of 1933, as amended (the “Securities Act”), to specifically disclose our compensation as well as other important information, This information includes that we may hold, as well as purchase and sell, the securities of a Profiled Issuer before, during and after we publish favorable Information about the Profiled Issuer. We may urge investors to purchase the securities of a Profiled Issuer while we sell our own shares. The anti-fraud provisions of federal and state securities laws require us to inform you that we may engage in buying and selling of Profiled Issuer’s securities before, during and after the Campaigns. What are other risks that investors should be aware of? Any investment in the Profiled Issuers involves a high degree of risk and uncertainty. The securities may be subject to extreme volume and price volatility, especially during the Campaigns. Favorable past performance of a Profiled Issuer does not guarantee future results. If you purchase the securities of the Profiled Issuers, you should be prepared to lose your entire investment. Some of the risks involved in purchasing securities of the Profiled Issuers include, but are not limited to the risks stated below.
  • We do not endorse, independently verify or assert the truthfulness, completeness, accuracy or reliability of the Information. We conduct no due diligence or investigation whatsoever of the Information or the Profiled Issuers and we do not receive any verification from the Profiled Issuer regarding the Information we disseminate.
  • If we publish any percentage gain of a Profiled Issuer from the previous day close in the Information, it is not and should not be construed as an indication that the future stock price or future operational results will reflect gains or otherwise prove to be advantageous to your investment.
  • The Information may contain statements asserting that a Profiled Issuer’s stock price has increased over a certain period of time which may reflect an arbitrary period of time, and is not predictive or of any analytical quality; as such, you should not rely upon the (favorable) Information in your analysis of the present or future potential of a Profiled Issuer or its securities.
  • The Information should not be interpreted in any way, shape, form or manner whatsoever as an indication of the Profiled Issuer’s future stock price or future financial performance.
  • You may encounter difficulties determining what, if any, portions of the Information are material or non-material, making it all the more imperative that you conduct your own independent investigation of the Profiled Issuer and its securities with the assistance of your legal, tax and financial advisor.
  • We or other stock promoters may receive free trading shares as compensation or we may acquire such shares in open market transactions before and during the Campaigns, and we may sell the shares we acquire at any time, even during the Campaigns while publishing the Favorable Information. When we sell the shares of the Profiled Issuers that we hold, the price at which investors can sell their shares will dramatically decrease and will likely cause investors to suffer trading losses.
  • We may sell securities of the Profiled Issuers for less than target prices set forth in the Information, and we may profit by selling our securities during the Campaigns while investors encounter losses.
  • When we acquire, purchase or sell the securities of the Profiled Issuers, it may (a) cause significant volatility in the Profiled Issuer’s securities; (b) cause temporary but unrealistic increases in volume and price of the Profiled Issuer’s securities; (c) if selling, cause the Profiled Issuer’s stock price to decline dramatically; and (d) permit us to make substantial profits while investors who purchase during the Campaign experience significant losses.
  • The securities of the Profiled Issuers are high risk, unstable, unpredictable and illiquid which may make it difficult for investors to sell their securities of the Profiled Issuers.
  • If we are compensated in improperly free trading securities of the Profiled Issuers, either directly or indirectly from persons who claim to be non-affiliates of such Profiled Issuer, we and the Profiled Issuer or third party could be subject to SEC Enforcement Action, including allegations of an illegal distribution in violation of Section 5(a) and 5(c) of the Securities Act.
  • We may hire third party service providers and stock promoters to electronically disseminate live news regarding the Profiled Issuers, yet we have no control over the content of and do not verify the information that the Profiled Issuers and/or third party service providers publish. These third party service providers are likely compensated for providing positive information about the Issuer and fail to disclose their compensation to you.
If a Profiled Issuer is an SEC reporting company, it could be delinquent (not current) in its periodic reporting obligations (i.e., in its quarterly and annual reports), or if it is an OTC Markets Pink Sheet quoted company, it may be delinquent in its Pink Sheet reporting obligations, which may result in OTC Markets posting a negative legend pertaining to the Profiled Issuer at www.otcmarkets.com, as follows: (i) “Limited Information” for companies with financial reporting problems, economic distress, or that are unwilling to file required reports with the Pink Sheets; (ii) “No Information,” which characterizes companies that are unable or unwilling to provide any disclosure to the public markets, to the SEC or the Pink Sheets; and (iii) “Caveat Emptor,” signifying buyers should be aware that there is a public interest concern associated with a company’s illegal spam campaign, questionable stock promotion, known investigation of a company’s fraudulent activity or its insiders, regulatory suspensions or disruptive corporate actions. If the Information states that a Profiled Issuer’s securities are consistent with the future economic trends or even if your independent research indicates that, you should be aware that economic trends have their own limitations, including: (a) that economic trends or predictions may be speculative; (b) consumers, producers, investors, borrowers, lenders and government may react in unforeseen ways and be affected by behavioral biases that we are unable to predict; (c) human and social factors may outweigh future economic trends that we state may or will occur; (d) clear cut economic predictions have their limitations in that they do not account for the fundamental uncertainty in economic life, as well as ordinary life; (e) economic trends may be disrupted by sudden jumps, disruptions or other factors that are not accounted for in economic trends analysis; in other words, past or present data predicting future economic trends may become irrelevant in light of new circumstances and situations in which uncertainty becomes reality rather than predicted economic outcome; or (f) if the trend predicted involves a single result, it ignores other scenarios that may be crucial to make a decision in the event of unknown contingencies. The Information is presented only as a brief snapshot of the Profiled Issuer and should only be used, at most, and if at all, as a starting point for you to conduct a thorough investigation of the Profiled Issuer and its securities. You should consult your financial, legal or other adviser(s) and avail yourself of the filings and information that may be accessed at www.sec.govwww.sec.gov, www.otcmarkets.com or other electronic media, including: (a) reviewing SEC periodic reports (Forms 10-Q and 10-K), reports of material events (Form 8-K), insider reports (Forms 3, 4, 5 and Schedule 13D); (b) reviewing Information and Disclosure Statements and unaudited financial reports filed with the OTCMarkets.com; (c) obtaining and reviewing publicly available information contained in commonly known search engines such as Google; and (d) consulting investment guides at www.sec.gov and www.finra.org. You should always be cognizant that the Profiled Issuers may not be current in their reporting obligations with the SEC and the OTC Markets and/or have negative legends and designations at otcmarkets.com. What we were paid to advertise the Profiled Issuers. The details of our compensation and the period of the Campaign is set forth below.
  • Name of Issuer & Ticker Symbol - Cannabis Global, Inc (CBGL)
  • Amount & Form of Compensation - $200,000.00 in Restricted Common Stock
  • Who Paid for the Campaign & Position with Company if any - Cannabis Global, Inc (CBGL)
  • Period of Campaign - 01/16/2021 - 01/16/2022
What securities of the Profiled Issuers do we hold? The positions we hold of the Profiled Issuer are set forth below. We plan to sell these securities during the Campaign.
  • Name of Issuer & Ticker Symbol - Cannabis Global, Inc (CBGL)
  • Number of Shares We or our Affiliates Hold - 1,006,542
  • Price We Paid Per Share - $0
  • Date Issued - 01/16/2021

Related Post

Register to Download the Presentation

Go to website

Join the club

Subscribe to this newsletter

This email is already subscribed.

Go to top